Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Females and Males.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Depressive disorders; Vasomotor symptoms
- Focus Pharmacodynamics
- 05 Aug 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 12 Apr 2010 New trial record